Clariant, along with its healthcare packaging business unit, is set to showcase its Tri Sorb molecular sieve desiccant tablets at this year’s Pharmapack Europe event.
The event will take place between 7 and 8 February in Paris.
The company has designed Tri Sorb molecular sieve desiccant tablets for USP moisture permeability testing.
The new tablets were developed for pharmaceutical and nutraceutical packagers who carry out moisture-permeation testing of unit-dose blister packaging as prescribed in USP.
Clariant’s Tri-Sorb tablets can be placed into blister headspaces either singly or in multiples in place of the actual drug product, helping to test and verify the moisture vapor transmission rate (MTVR) of blister packaging as per the USP standard.
According to the company, the tablets will be packaged in quantities desirable for laboratory testing applications, with 320-350 tablets, depending on tablet size, in each re-sealable aluminium pouch.
To protect product integrity and moisture adsorbtion capacity, Tri-Sorb desiccant tablets will not be repackaged by a third party, but will be packaged directly on-site as part of the manufacturing process
At the event, the firm will also exhibit a range of controlled-atmosphere packaging solutions, including pharmaceutical desiccants, equilibrium sorbents, adsorbent polymers, oxygen scavengers and pharmaceutical closures and containers.
In November 2017, Clariant started operations of a new healthcare packaging facility in the Indian state of Tamil Nadu.
Located in Cuddalore, the new facility will produce the company's line of Sorb-it, Tri-Sorb, 2-in-1 Can, and Getter Can sorbent canisters for the Indian and Asia-Pacific pharmaceutical packaging markets.
The facility produces products, which are in line with the US FDA, USP and EU standards for use in pharmaceutical applications.